Literature DB >> 22002951

Cloacal exstrophy: an epidemiologic study from the International Clearinghouse for Birth Defects Surveillance and Research.

Marcia L Feldkamp1, Lorenzo D Botto, Emmanuelle Amar, Marian K Bakker, Eva Bermejo-Sánchez, Sebastiano Bianca, Mark A Canfield, Eduardo E Castilla, Maurizio Clementi, Melinda Csaky-Szunyogh, Emanuele Leoncini, Zhu Li, R Brian Lowry, Pierpaolo Mastroiacovo, Paul Merlob, Margery Morgan, Osvaldo M Mutchinick, Anke Rissmann, Annukka Ritvanen, Csaba Siffel, John C Carey.   

Abstract

Cloacal exstrophy presents as a complex abdominal wall defect thought to result from a mesodermal abnormality. Anatomically, its main components are Omphalocele, bladder Exstrophy and Imperforate anus. Other associated malformations include renal malformations and Spine defects (OEIS complex). Historically, the prevalence ranges from 1 in 200,000 to 400,000 births, with higher rates in females. Cloacal exstrophy is likely etiologically heterogeneous as suggested by its recurrence in families and occurrence in monozygotic twins. The defect has been described in infants with limb-body wall, with trisomy 18, and in one pregnancy exposed to Dilantin and diazepam. Due to its rarity, the use of a nonspecific diagnostic code for case identification, and lack of validation of the clinical findings, cloacal exstrophy remains an epidemiologic challenge. The purpose of this study was to describe the prevalence, associated anomalies and maternal characteristics among infants born with cloacal exstrophy. We used data from the International Clearinghouse for Birth Defects Surveillance and Research submitted from 18 birth defect surveillance programs representing 24 countries. Cases were clinically evaluated locally and reviewed centrally by two authors. Cases of persistent cloaca were excluded. A total of 186 cases of cloacal exstrophy were identified. Overall prevalence was 1 in 131,579 births: ranging from 1 in 44,444 births in Wales to 1 in 269,464 births in South America. Live birth prevalence was 1 in 184,195 births. Prevalence ratios did not vary by maternal age. Forty-two (22.6%) cases met the criteria for the OEIS complex, whereas 60 (32.3%) were classified as OEI and 18 (9.7%) as EIS (one with suspected VATER (0.5%)). Other findings included two cases with trisomy 13 (one without a karyotype confirmation), one with mosaic trisomy 12 (0.5%), one with mosaic 45,X (0.5%) and one classified as having amnion band sequence (0.5%). Twenty-seven (14.5%) infants had other anomalies unrelated to cloacal exstrophy. Cloacal exstrophy is a rare anomaly with variability in prevalence by geographic location. The proportion of cases classified as OEIS complex was lower in this study than previously reported. Among all cases, 54.8% were reported to have an omphalocele.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22002951     DOI: 10.1002/ajmg.c.30317

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  15 in total

Review 1.  Bladder exstrophy: an epidemiologic study from the International Clearinghouse for Birth Defects Surveillance and Research, and an overview of the literature.

Authors:  Csaba Siffel; Adolfo Correa; Emmanuelle Amar; Marian K Bakker; Eva Bermejo-Sánchez; Sebastiano Bianca; Eduardo E Castilla; Maurizio Clementi; Guido Cocchi; Melinda Csáky-Szunyogh; Marcia L Feldkamp; Danielle Landau; Emanuele Leoncini; Zhu Li; R Brian Lowry; Lisa K Marengo; Pierpaolo Mastroiacovo; Margery Morgan; Osvaldo M Mutchinick; Anna Pierini; Anke Rissmann; Annukka Ritvanen; Gioacchino Scarano; Elena Szabova; Richard S Olney
Journal:  Am J Med Genet C Semin Med Genet       Date:  2011-10-14       Impact factor: 3.908

2.  ESPR uroradiology task force imaging recommendations in paediatric uroradiology, part VII: standardised terminology, impact of existing recommendations, and update on contrast-enhanced ultrasound of the paediatric urogenital tract.

Authors:  Michael Riccabona; Pierr-Hughes Vivier; Akaterina Ntoulia; Kassa Darge; Fred Avni; Frederika Papadopoulou; Beatrice Damasio; Lil-Sophie Ording-Muller; Johan Blickman; Maria-Luisa Lobo; Ulrich Willi
Journal:  Pediatr Radiol       Date:  2014-10-21

3.  Development of the ventral body wall in the human embryo.

Authors:  Hayelom K Mekonen; Jill P J M Hikspoors; Greet Mommen; S Eleonore Köhler; Wouter H Lamers
Journal:  J Anat       Date:  2015-11       Impact factor: 2.610

Review 4.  Lower urinary tract development and disease.

Authors:  Hila Milo Rasouly; Weining Lu
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2013-02-13

Review 5.  Cloacal exstrophy with extensive Chiari II malformation: case report and review of the literature.

Authors:  Obed M Nyarenchi; Andrea Scherer; Saul Wilson; Daniel H Fulkerson
Journal:  Childs Nerv Syst       Date:  2013-06-13       Impact factor: 1.475

6.  Clinical and risk factor analysis of cloacal defects in the National Birth Defects Prevention Study.

Authors:  Kim M Keppler-Noreuil; Kristin M Conway; Dereck Shen; Anthony J Rhoads; John C Carey; Paul A Romitti
Journal:  Am J Med Genet A       Date:  2017-09-28       Impact factor: 2.802

7.  Value of sharing and networking among birth defects surveillance programs: an ICBDSR perspective.

Authors:  Eva Bermejo-Sánchez; Lorenzo D Botto; Marcia L Feldkamp; Boris Groisman; Pierpaolo Mastroiacovo
Journal:  J Community Genet       Date:  2018-09-18

8.  Genetics of Bladder-Exstrophy-Epispadias Complex (BEEC): Systematic Elucidation of Mendelian and Multifactorial Phenotypes.

Authors:  Heiko Reutter; Kim Keppler-Noreuil; Catherine E Keegan; Holger Thiele; Gen Yamada; Michael Ludwig
Journal:  Curr Genomics       Date:  2016-02       Impact factor: 2.236

9.  Blastopathies and microcephaly in a Chornobyl impacted region of Ukraine.

Authors:  Wladimir Wertelecki; Lyubov Yevtushok; Natalia Zymak-Zakutnia; Bin Wang; Zoriana Sosyniuk; Serhiy Lapchenko; Holly H Hobart
Journal:  Congenit Anom (Kyoto)       Date:  2014-08       Impact factor: 1.409

10.  [Profile of patients with genitourinary anomalies treated in a clinical genetics service in the Brazilian unified health system].

Authors:  Ilanna Fragoso Peixoto Gazzaneo; Camila Maia Costa de Queiroz; Larissa Clara Vieira Goes; Victor José Correia Lessa; Reinaldo Luna de Omena Filho; Diogo Lucas Lima do Nascimento; Reginaldo José Petroli; Susane Vasconcelos Zanotti; Isabella Lopes Monlleó
Journal:  Rev Paul Pediatr       Date:  2015-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.